Table 1: Summarization of the characteristics of the included studies.
|
OSA |
Control |
||||||||||||||
|
Author /year |
Country |
Time |
OSA diagnosis |
OSA severity |
MASLD diagnosis |
Population |
Excluded OSA cases? |
MASLD/ Total OSA |
ALT (mean ± SD) |
AST (mean ± SD) |
MASLD/ Mild or moderate OSA |
MASLD/ Severe OSA |
MASLD/Control |
ALT (mean ± SD) |
AST (mean ± SD) |
|
Jin, et al. 2023 [18] |
China |
1/2015: 10/2019 |
Full-night PSG |
AASM Criteria |
Abdominal Ultrasound (US) following The Chinese Liver Disease association criteria |
Subjects ≥ 60 years attending sleep laboratory owing to sleep apnea symptoms |
Yes |
139/201 |
22.41 ± 10.43 |
21.96 ± 7.92 |
75/107 |
64/94 |
11/26 |
19.59 ± 12.33 |
20.34± 7.27 |
|
Huang, et al. 2023 [19] |
China |
1/2013: 12/2020 |
Full-night PSG |
AASM Criteria |
Hepatic steatosis (diagnosed by US) in addition to other criteria for metabolic dysregulation |
Patients attending sleep centers owing to clinical suspicion of sleep-disordered breathing |
Yes |
732/967 |
— |
— |
302/417 |
430/550 |
57/98 |
— |
— |
|
Lian, et al. 2022 [20] |
China |
1/2016: 12/2019 |
Full-night PSG |
AASM Criteria |
Abdominal US and an exclusion of excessive alcohol intake |
Patients attending sleep center owing to clinical suspicion of sleep apnea |
No |
228/351 |
26.87 ± 14.64 |
23.91 ± 11.79 |
121/190 |
107/161 |
33/59 |
21 ± 13.07 |
21 ± 7 |
|
Landete, et al. 2022 [21] |
Spain |
— |
Full-night PSG |
— |
Fatty liver index (FLI) ≥ 60 and no excessive alcohol consumption |
Consecutive patients attending the outpatient clinics of pneumology with clinical or polysomnographic criteria for OSA |
No |
95/153 |
24.4 ± 13.2 |
23.1 ± 10.8 |
— |
— |
15/43 |
22.7 ± 13.1 |
21.3 ± 6.5 |
|
Tomar, et al. 2021 [22] |
India |
1/2013: 2/2020 |
Full-night PSG |
— |
US or liver biopsy |
Hepatic patients undergoing PSG assessment in the pulmonary medicine department |
No |
29/32 |
— |
— |
— |
— |
27/46 |
— |
— |
|
Lu, et al. 2021 [23] |
China |
6/2017: 6/2020. |
Full-night PSG |
— |
Hepatic steatosis index (HSI) > 36 |
Adult subjects with NAFLD suspicion undergoing PSG |
Yes |
31/46 |
34.67 ± 19.9 |
27 ± 10.71 |
— |
— |
6/13 |
24.33 ± 11.63 |
24 ± 4.98 |
|
Ding, et al. 2019 [24] |
China |
1/2016: 1/2018 |
Full-night PSG |
AASM Criteria |
Abdominal US and an exclusion of excessive alcohol intake |
Consecutive subjects referred to the sleep department |
Yes |
276/372 |
35.36 ± 26.39 |
26.06 ± 20.94 |
105/153 |
171/219 |
16/43 |
20.66 ± 12.1 |
21.56± 7.75 |
|
Benotti, et al. 2016 [25] |
USA |
11/2006: 10/2014 |
PSG |
AASM Criteria |
Intraoperative wedge liver biopsy |
Obese patients enrolled in a bariatric surgery program in a weight management center |
No |
230/269 |
31.66 ± 19.07 |
27.16 ± 16.73 |
166/195 |
64/74 |
70/93 |
30 ± 17.5 |
26.2 ± 11.9 |
|
Yu, et al. 2015 [26] |
South Korea |
9/2009: 11/2010 |
Full-night PSG |
- |
Liver attenuation index value < 5 HU and an exclusion of excessive alcohol intake |
Subjects from another Korean study cohort who underwent PSG |
No |
97/286 |
24.55 ± 11.14 |
24.84 ± 6.18 |
— |
— |
70/335 |
22.23 ±10.85 |
23.38± 5.07 |